Arkolith/Insider Trading/ANIK/Form 4

Blanchard Cheryl R

DirectorAnika Therapeutics, Inc. (ANIK) · full profile →Form 4 · filed Mar 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 15, 2026Option exercise(M)25K——271K
Mar 15, 2026Tax withholding(F)12K$14.20$172K259K
Mar 14, 2026Option exercise(M)25K——236K
Mar 14, 2026Tax withholding(F)15K$14.20$209K246K
Mar 14, 2026Grant(A)25K—$0260K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 15, 2026Option exercise(M)25K—$025K
Mar 14, 2026Option exercise(M)25K—$049K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-111494) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML